| Literature DB >> 33478803 |
Manfred Hauben1, Craig G Hartford2.
Abstract
Artificial intelligence (AI), a highly interdisciplinary science, is an increasing presence in pharmacovigilance (PV). A better understanding of the scope of artificial intelligence in pharmacovigilance (AIPV) may be advantageous to more sharply defining, for example, which terms, methods, tasks, and data sets are suitably subsumed under the application of AIPV. Accordingly, this article explores relevant points to consider regarding defining the scope of AIPV and offers a potential working definition of the scope of AIPV.Keywords: AI; artificial intelligence; machine learning; pharmacovigilance; technology
Year: 2021 PMID: 33478803 DOI: 10.1016/j.clinthera.2020.12.014
Source DB: PubMed Journal: Clin Ther ISSN: 0149-2918 Impact factor: 3.393